Proving that pharmaceutical care makes a difference in community pharmacy

Journal of the American Pharmacists Association

Volumn 43, Issue 2, 2003, Pages 136-139

  Posey, L Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; ARTICLE; COMPARATIVE STUDY; ECONOMICS; HUMAN; PATIENT CARE; PHARMACY; TREATMENT OUTCOME;

AMBULATORY CARE; COMMUNITY PHARMACY SERVICES; HUMANS; PATIENT CARE; TREATMENT OUTCOME;

EID: 0038100642     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/108658003321480669     Document Type: Article

References (30)

1. Pharmacy in the 21st Century. Alexandria, Va: American Association of Colleges of Pharmacy; 1984.
2. Hepler CD. Pharmacy as a clinical profession. Am J Hosp Pharm. 1985;42:1298-306.
3. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
4. Cranor CW, Christensen DB. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:160-72.
5. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
6. Garrett DG, Martin LA. The Asheville Project: participants' perceptions of factors contributing to the success of a patient self-management diabetes program. J Am Pharm Assoc. 2003;43:185-90.
7. Garcao JA, Cabrita J. Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal. J Am Pharm Assoc. 2002; 42:858-64.
8. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA. 2002; 288:1594-602.
9. Stergachis A, Gardner JS, Anderson MT, Sullivan SD. Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc. 2002;42:743-52.
10. Alvarez de Toledo F, Arcos Gonzalez P, Eyaralar Riera T, et al. Pharmaceutical care in people who have had acute coronary episodes (TOMCOR study) [in Spanish]. Rev Esp Salud Publica. 2001;75: 375-87.
11. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21:1196-203.
12. Volume CI, Farris KB, Kassam R, et al. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc. 2001;41:411-20.
13. Bernsten C, Bjorkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy- based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18:63-77.
14. Barnett CW, Nykamp D, Ellington AM. Patient-guided counseling in the community pharmacy setting. J Am Pharm Assoc. 2000;40:765-72.
15. Nola KM, Gourley DR, Portner TS, et al. Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. J Am Pharm Assoc. 2000; 40:166-73.
16. Currie JD, Chrischilles EA, Kuehl AK, Buser RA. Effect of a training program on community pharmacists' detection of and intervention in drug-related problems. J Am Pharm Assoc. 1997;NS37: 182-91.
17. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc. 1996;NS36:443-51.
18. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
19. Pearson TA, Laurora I, Chu H, Kafonek S. The Lipid Treatment Assessment Project (LTAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000;160:459-67.
20. Carter BL, Chrischilles EA, Scholz D, et al. Extent of services provided by pharmacists in the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc. 2003;43:24-33.
21. Herborg H, Soendergaard B, Froekjaer B, et al. Improving drug therapy for patients with asthma - part 1: patient outcomes. J Am Pharm Assoc. 2001;41:539-50.
22. Herborg H, Soendergaard B, Jorgensen T, et al. Improving drug therapy for patients with asthma - part 2: use of anti-asthma medications. J Am Pharm Assoc. 2001;41:539-50.
23. Christensen DB, Holmes G, Fassett WE, et al. Influence of a financial incentive on cognitive services: CARE project design/implementation. J Am Pharm Assoc. 1999;39:629-39.
24. Christensen DB, Hansen RW. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting. J Am Pharm Assoc. 1998;39:640-9.
25. Smith DH, Fassett WE, Christensen DB. Washington State CARE project: downstream cost changes associated with the provision of cognitive services by pharmacists. J Am Pharm Assoc. 1999;39:650-7.
26. Christensen DB, Neil N, Fassett WE, et al. Frequency and characteristics of cognitive services provided in response to a financial incentive. J Am Pharm Assoc. 2000;40:609-17.
27. Sesquicentennial Stepping Stone Summits - Summit one: the best use of technology in pharmacy practice. J Am Pharm Assoc. 2003;43:140-7.
28. Flynn EA, Barker KN, Carnahan B. National observational study of prescription dispensing safety in 50 pharmacies. J Am Pharm Assoc. 2003;43:191-200.
29. Sesquicentennial Stepping Stone Summits - Summit two: pharmacy technicians. J Am Pharm Assoc. 2003; 43:84-92.
30. White paper on pharmacy technicians (2002): needed changes can no longer wait. J Am Pharm Assoc. 2003; 43:93-107.